Assessing the Growing Role & the Demand of Apps in Managing the Chronic Diseases

Neurology

Insilico Medicine raises $255M; Sanofi & T...

Insilico Medicine raises USD 255 Million for AI drug discovery Insilico Medicine, a Hong Kong-based global leader in end-to-end artificial intelligence for target discovery, small molecule chemistr...

Jun 24, 2021

technology-and-autism-spectrum-disorder
Does the use of Assistive Technologies in Autism Spectrum Disorder Payoff?

Autism Spectrum Disorder (ASD) is a complex neurological and developmental condition that impacts a person’s social, communication, and behavioral aspects of life. It results in persistent restricted, repetitive patterns of behavior or interests.  It is a lifelong condition and mainly appears during the early ...

Find More
Horizon-Arrowhead-deal-Dr-Reddy-Lab-Drug-US-Launch-Targovax-ONCOS-102;-RedHill-Oral-Opaganib-COVID-19
Horizon/ Arrowhead Deal; Dr Reddy’s Lab’s Drug US Launch; Targovax’s ONCOS-102; RedHill’s Oral Opaganib in COVID-19

Horizon Dishes Out Million Dollars to get Arrowhead's RNAi Drug Arrowhead Pharmaceuticals and Horizon Therapeutics have announced a research and development collaboration to advance the treatment landscape for uncontrolled gout. Under the terms and conditions, Arrowhead is bound to receive an upfront sum of U...

Find More
recent-pharma-happenings-for-mallinckrodt-rayzebio-vectory-umoja
Mallinckrodt earns FDA nod for skin therapy; RayzeBio secures $108M; VectorY raises $38M; Umoja banks $210M

Mallinckrodt earns FDA nod for regenerative skin therapy for burns Mallinckrodt plc’s Stratagraft gained FDA approval for use in deep partial-thickness thermal burns. The company said regenerative skin tissue therapy could lessen or eliminate the requirement of autografting of healthy skin to treat burn wounds. ...

Find More

More Views & Analysis

MedTech-News-updates-Eclipse-Medtronic-Aethlon-Cognoa-ObvioHealth
Eclipse, Medtronic, Aethlon, Cognoa, ObvioHealth, and others Continue to Veer MedTech Market Forward

Eclipse Launches MicroPen EVO™ Advanced Micro-needling Device On June 01, 2021, Eclipse, a leading aesthetic and medical manufacturer, received FDA clearance of their latest medical-grade micro-needling device, the MicroPen EVO. It had launched MicroPen EVO in Canada last year and now will make it availab...

Find More

Leading MedTech Companies 2021| Abbott | Medtronic | J&J | Boston Scientific |
Medical Devices Market Blooms as the Key MedTech Companies Continue to Bring-In Innovation

The global coronavirus has affected almost every industry, and medical devices are no less affected. Even as the first quarter of 2021 has passed, the pandemic hasn’t. No industry has gone unharmed amidst the pandemic, and similarly, the healthcare industry is also witnessing the impact of the resurgence of the vir...

Find More

Spinal Stenosis Devices Market | Medical Devices Market | MedTech Market
Spinal Stenosis Devices Market Size to Balloon Up Owing to Increasing Prevalence & Geriatric Population, as well as Medical Advancements

Spinal stenosis refers to the condition characterized by the compression of nerve roots and narrowing of the spinal canal due to several pathologic factors, further leading to symptoms such as pain with a tingling sensation, numbness, and weakness. Spinal stenosis can involve the cervical, lumbar, or thoracic (rare...

Find More

recent-pharma-news-updates-for-biogen-novo-nordisk-bluebird-bio
Biogen’s Alzheimer’s Drug; FDA approval to Novo Nordisk’s Wegovy; Bluebird’s Gene Therapy

Verdict for Biogen’s Long-Awaited Alzheimer’s Drug Is Finally Here   The USFDA finally gave approval to eagerly-anticipated Biogen’s Drug Aducanumab for the treatment of Alzheimer’s disease under the accelerated approval pathway. The drug, marketed under the name Aduhelm, is the first that treats an un...

Find More

Chronic Pain Associated With Painful Diabetic Neuropathy Market
Global Chronic Pain Associated With Painful Diabetic Neuropathy Market Landscape

Neuropathy is the most usual complication that occurs due to diabetes, affecting up to about 50% of the patients. Painful diabetic neuropathy tends to take place in ~25% of the patients suffering from diabetes mellitus. These patients get treated in office settings, and it affects their quality of life. It also occ...

Find More

recent-pharma-happenings-for-pfizer-abcellera-sarepta-eli-lilly
Pfizer hit by DMD delay & halts BCMA trials; Sarepta’s drug shows promise in Phase II; Human organ chips enable COVID-19 drug repurposing; AbCellera takes new antibody into clinic

Pfizer suffers a DMD delay and halts BCMA trials amid safety woes  Pfizer has paused after seeing three cases of peripheral neuropathy in an early-stage study, enrollment in a critical analysis of its anti-BCMA bispecific antibody. Big Pharma shares news with details of delays to the start of the US part of...

Find More

Affecting the entire body, Adult Onset Still's disease (AOSD) is a rare type of inflammatory arthrit.....

Find More

Xerostomia is a condition characterized by dry mouth, which is a result of a reduced or absent flow .....

Find More

Acute myeloid leukemia (AML), also called acute myelogenous leukemia and acute nonlymphocytic leukem.....

Find More

Immune thrombocytopenic purpura (ITP) is a disorder that results in the immune system killing its pl.....

Find More

According to WHO, Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death g.....

Find More

An autosomal metabolic disorder – Pompe disease results in deterioration of organs and tissues as .....

Find More